ArticleHemaSphere2021

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia.

Colin Vercueil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.